Issue 2 - The Cancer Letter

Vol.

No.

January 12, 2018Jan 12, 2018

Free

DOWNLOAD THE PDF

Roche funds effort by Syapse to build software for measuring outcomes in precision oncology

Cover Story

Free

Roche funds effort by Syapse to build software for measuring outcomes in precision oncology

By Matthew Bin Han Ong

Roche has teamed up with the precision medicine company Syapse to develop software for measuring health outcomes and economic impact of precision medicine.

Conversation with The Cancer Letter Free

Syapse: Roche collaboration enables us to experiment with new technology

By Matthew Bin Han Ong

Conversation with The Cancer Letter Free

Hostin: Roche-Syapse programs will increase amount and depth of risk-benefit info in precision oncology

By Matthew Bin Han Ong

Free Obituary

Robert W. Day, former president of Fred Hutchinson, dies at 87

By Gary Gilliland

Free Obituary

Marsha Fountain Woznuck, nurse and pioneering cancer center administrator, dies at 65

By Catherine Harvey Sevier

Clinical Free Trials & Tribulations

How disease-specific clinical trial finders can address gaps in study participation

By David F. Arons

In Brief

Emory receives $400 million pledge from Woodruff Foundation

Children's Mercy Kansas City receives gifts—totaling $150 million

Mary Beckerle receives NCI Knudson Award

Chi Van Dang as editor-in-chief of AACR journal Cancer Research

Mark Israel named executive director of Israel Cancer Research Fund

International Association for the Study of Lung Cancer becomes member of registry of real-world data

Elizabeth Barrett named CEO of Novartis Oncology

Funding Opportunities

LUNGevity issues RFA for 2018 Career Development Award in translational research in lung cancer

Clinical Roundup

Yale study demonstrates four-fold superiority of academic level diagnostic accuracy

Researchers demonstrate RAS dimers are essential for cancer

Xenoestrogens in foods may counteract breast cancer treatment

Drugs & Targets

FDA expands indications for AZ's Lynparza, making it first treatment for breast cancer with BRCA mutation

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Syapse: Roche collaboration enables us to experiment with new technology

Hostin: Roche-Syapse programs will increase amount and depth of risk-benefit info in precision oncology

Robert W. Day, former president of Fred Hutchinson, dies at 87

Marsha Fountain Woznuck, nurse and pioneering cancer center administrator, dies at 65

How disease-specific clinical trial finders can address gaps in study participation

In Brief

Emory receives $400 million pledge from Woodruff Foundation

Children's Mercy Kansas City receives gifts—totaling $150 million

Mary Beckerle receives NCI Knudson Award

Chi Van Dang as editor-in-chief of AACR journal Cancer Research

Mark Israel named executive director of Israel Cancer Research Fund

International Association for the Study of Lung Cancer becomes member of registry of real-world data

Elizabeth Barrett named CEO of Novartis Oncology

Funding Opportunities

LUNGevity issues RFA for 2018 Career Development Award in translational research in lung cancer

Clinical Roundup

Yale study demonstrates four-fold superiority of academic level diagnostic accuracy

Researchers demonstrate RAS dimers are essential for cancer

Xenoestrogens in foods may counteract breast cancer treatment

Drugs & Targets

FDA expands indications for AZ's Lynparza, making it first treatment for breast cancer with BRCA mutation

Recent Issues

Trending Stories

Renew today!

Subscriber content

Login